carbogen has been researched along with misonidazole in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herman, TS; Holden, SA; Jones, SM; Teicher, BA | 1 |
Denekamp, J; Johns, H; Joiner, B; Joiner, M; Stevens, G | 1 |
Dische, S; Hoskin, PJ; Saunders, MI | 1 |
Droller, MJ | 1 |
Bentzen, L; Falborg, L; Hansen, SB; Horsman, MR; Keiding, S; Overgaard, J | 1 |
Bentzen, L; Grönroos, T; Hansen, SB; Horsman, MR; Keiding, S; Overgaard, J | 1 |
1 trial(s) available for carbogen and misonidazole
Article | Year |
---|---|
Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
Topics: Adult; Aged; Carbon Dioxide; Humans; Hyperbaric Oxygenation; Middle Aged; Misonidazole; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage; Urinary Bladder Neoplasms | 1999 |
5 other study(ies) available for carbogen and misonidazole
Article | Year |
---|---|
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Drug Combinations; Etanidazole; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
Radiosensitization of mouse skin by oxygen and depletion of glutathione.
Topics: Animals; Buthionine Sulfoximine; Carbon Dioxide; Cell Hypoxia; Dose-Response Relationship, Radiation; Female; Glutathione; Male; Maleates; Methionine Sulfoximine; Mice; Misonidazole; Oxygen; Oxygen Consumption; Partial Pressure; Radiation-Sensitizing Agents; Skin; Tourniquets | 1995 |
Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide.
Topics: Carbon Dioxide; Humans; Hyperbaric Oxygenation; Misonidazole; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms | 2000 |
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Topics: Animals; Binding Sites; Carbon Dioxide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hypoxia; Mammary Neoplasms, Experimental; Mice; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.
Topics: Animals; Autoradiography; Carbon Dioxide; Cell Hypoxia; Electrodes; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Tomography, Emission-Computed | 2002 |